stoxline Quote Chart Rank Option Currency Glossary
  
Rapid Micro Biosystems, Inc. (RPID)
1.135  0.015 (1.34%)    12-07 15:09
Open: 1.1
High: 1.15
Volume: 53,850
  
Pre. Close: 1.12
Low: 1.04
Market Cap: 42(M)
Technical analysis
2023-12-07 4:23:08 PM
Short term     
Mid term     
Targets 6-month :  1.37 1-year :  1.6
Resists First :  1.17 Second :  1.37
Pivot price 1.08
Supports First :  1.02 Second :  0.92
MAs MA(5) :  1.11 MA(20) :  1.06
MA(100) :  1.01 MA(250) :  1.11
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  65.9 D(3) :  66.9
RSI RSI(14): 60
52-week High :  1.88 Low :  0.82
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ RPID ] has closed below upper band by 24.7%. Bollinger Bands are 39.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.15 - 1.16 1.16 - 1.17
Low: 1.02 - 1.03 1.03 - 1.04
Close: 1.12 - 1.14 1.14 - 1.15
Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Headline News

Wed, 08 Nov 2023
Will Rapid Micro Biosystems Inc (RPID) Stay at the Top of the Healthcare Sector? - InvestorsObserver

Mon, 06 Nov 2023
Is Rapid Micro Biosystems Inc (RPID) Stock at the Top of the Medical Devices Industry? - InvestorsObserver

Sun, 05 Nov 2023
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2023 Earnings Call Transcript - Yahoo Finance

Fri, 03 Nov 2023
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results - Yahoo Finance

Fri, 03 Nov 2023
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Wed, 07 Dec 2022
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 37 (M)
Shares Float 20 (M)
Held by Insiders 12 (%)
Held by Institutions 73.6 (%)
Shares Short 7 (K)
Shares Short P.Month 12 (K)
Stock Financials
EPS -1.35
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3
Profit Margin -280.9 %
Operating Margin -235.2 %
Return on Assets (ttm) -21.9 %
Return on Equity (ttm) -37.7 %
Qtrly Rev. Growth 29.7 %
Gross Profit (p.s.) -0.24
Sales Per Share 0.55
EBITDA (p.s.) -1.59
Qtrly Earnings Growth 0 %
Operating Cash Flow -47 (M)
Levered Free Cash Flow -29 (M)
Stock Valuations
PE Ratio -0.85
PEG Ratio 0
Price to Book value 0.37
Price to Sales 2.04
Price to Cash Flow -0.9
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android